Ambev S.A. filings document the reporting cycle of a Brazilian foreign private issuer with NYSE ADRs and B3-listed common shares. Form 20-F reports cover audited financial statements and annual business disclosure, while Form 6-K submissions furnish interim consolidated financial statements, quarterly operating results and current reports under Exchange Act rules for foreign issuers.
The filing record also covers beverage segment performance in Brazil Beer, Brazil NAB, Latin America South, Central America and the Caribbean, and Canada; capital allocation through interest on capital; treasury share activity; management and related-person securities transactions under Brazilian CVM rules; shareholder-meeting voting maps; board resolutions; committee matters; compensation; and other governance disclosures.
AMBEV S.A. director Marcos de Barros Lisboa filed a Form 3 reporting his initial holdings. He directly owns 20,115 common shares, several blocks of restricted shares that vest between December 1, 2026 and December 1, 2030, and stock options on 43,169, 40,064, 52,949 and 72,370 common shares with exercise prices between $3.22 and $3.91 expiring from December 2, 2026 through December 3, 2029. The restricted shares each represent a contingent right to receive one common share, net of withholding taxes.
AMBEV S.A. director Michel D. Doukeris filed an initial insider ownership report on Form 3. The filing identifies him as a director of the company but does not list any insider transactions or derivative positions at this time.
AMBEV S.A. officer Malik Parente Guilherme filed an initial Form 3 showing existing equity interests in the company. The report lists direct holdings of Common Shares as well as several blocks of Restricted Shares, each representing a right to receive one common share minus withholding taxes.
Restricted share grants include awards tied to December 1, 2026, March 1, 2027, December 2, 2027, February 28, 2028 and December 1, 2028 vesting dates. The filing also shows multiple stock option positions over common shares with exercise prices between 3.26 and 3.91 and expirations from March 31, 2026 through December 3, 2029. No new purchases or sales are reported; it is a snapshot of current holdings.
AMBEV S.A. director Fernando Tennenbaum filed a Form 3 reporting his holdings of stock options on the company’s common shares. The data shows stock options with rights to buy 205,698 shares at an exercise price of 3.2200 per share, expiring on December 4, 2028, and additional options over 253,317 shares at an exercise price of 3.4300, expiring on December 3, 2029. All positions are reported as held directly.
AMBEV S.A. director Moreira Ricardo Manuel Frangatos Pires filed an initial ownership report showing beneficial ownership of 3,468,040 common shares, held directly. The total includes certain common shares represented by American Depositary Shares, each ADS corresponding to one common share.
AMBEV S.A. director Fabio Colletti Barbosa has filed an initial ownership report showing multiple grants of restricted shares. Each restricted share represents a contingent right to receive one common share, minus withholding taxes, with vesting dates on December 1, 2026, December 1, 2027, December 1, 2028, December 2, 2029 and December 1, 2030. The filing lists these holdings as directly owned and does not show any buys or sells.
Ambev S.A. reported management and related-party trading in its securities for the period from February 1 to 28, 2026, under Brazilian CVM Instruction 44. The board of directors and fiscal council showed no changes in their positions, with initial and final balances remaining the same.
For management, common share holdings moved from 5,208,794 shares and 19,790 ADRs at the start of the month to 4,585,877 common shares and 19,790 ADRs at month-end. The report lists numerous market sales of common shares through XP Corretora and a return of lent securities via XP Investimentos.
Ambev S.A. filed a Form 6-K detailing its own share movements for February 2026 under Brazilian CVM Instruction 44/2021. The company used treasury shares for the delivery of restricted shares on three dates during the month.
Ambev started the month with 145,113,436 common shares held in treasury and no ADRs. It delivered 1,942 shares on February 2, 220,383 shares on February 13, and 20,585 shares on February 16, for total cash volumes in reais matching the stated prices. After these transactions, the treasury balance was 144,870,526 common shares and zero ADRs.
Ambev S.A. filed its annual report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission. The report is available on Ambev’s investor relations website and on the SEC’s EDGAR system. Holders of Ambev ADRs can request a hard copy of the complete audited financial statements contained in the Form 20-F free of charge.